Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BCHE | P06276 | 5/20 | 0.54 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
| ▸ | MRGPRX4 | Q96LA9 | 6/20 | 0.45 |
| ▸ | RXRA | P19793 | 1/20 | 0.44 |
| ▸ | RXRB | P28702 | 1/20 | 0.44 |
| ▸ | RXRG | P48443 | 1/20 | 0.44 |
| ▸ | HTR1A | P08908 | 2/20 | 0.43 |
| ▸ | HTR2C | P28335 | 1/20 | 0.43 |
| ▸ | HTR7 | P34969 | 1/20 | 0.43 |
| ▸ | HTR2B | P41595 | 1/20 | 0.43 |
| ▸ | HTR5A | P47898 | 1/20 | 0.43 |
| ▸ | HTR6 | P50406 | 1/20 | 0.43 |
| ▸ | ADRA1D | P25100 | 1/20 | 0.41 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.41 |
| ▸ | ADRA1B | P35368 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12600530 | 0.85 | MRGPRX4 (0.58) | BCHEMRGPRX4HTR1AHTR2CHTR7 | |
| SCHEMBL15309708 | 0.84 | MAPT (0.51) | L3MBTL1MAPTMAPK1TDP1MRGPRX4 | |
| SCHEMBL12600483 | 0.84 | BCHE (0.52) | BCHEL3MBTL1MRGPRX4HTR1A | |
| SCHEMBL12600485 | 0.83 | MRGPRX4 (0.58) | BCHEMAPTMRGPRX4 | |
| SCHEMBL12600488 | 0.82 | BCHE (0.50) | BCHEL3MBTL1MAPTMAPK1TDP1 | |
| SCHEMBL12600518 | 0.80 | BCHE (0.75) | BCHEL3MBTL1MAPK1MRGPRX4 | |
| SCHEMBL12330370 | 0.78 | MRGPRX4 (0.55) | L3MBTL1MAPTMAPK1TDP1MRGPRX4 | |
| SCHEMBL8621333 | 0.78 | MAPT (0.51) | L3MBTL1MAPTMAPK1TDP1MRGPRX4 | |
| SCHEMBL8283224 | 0.78 | FFAR4 (0.56) | L3MBTL1MAPTMAPK1TDP1MRGPRX4 | |
| SCHEMBL7766011 | 0.77 | HRH3 (0.56) | BCHEL3MBTL1MAPTMAPK1TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2499112-B1 | SUBSTITUTED 3-(PHENOXYMETHYL) BENZYL AMINES AND PERSONAL CARE COMPOSITIONS | UNILEVER PLC NO 41424 (GB) | 2013-10-16 | — | — | EP | disclosed |
| US-8425885-B2 | Substituted 3-(phenoxymethyl) benzyl amines and personal care compositions | CONOPCO, INC. (US) | 2013-04-23 | — | — | US | disclosed |
| US-8425885-B2 | Substituted 3-(phenoxymethyl) benzyl amines and personal care compositions | CONOPCO, INC. (US) | 2013-04-23 | — | — | US | disclosed |
| US-20110110871-A1 | SUBSTITUTED 3-(PHENOXYMETHYL) BENZYL AMINES AND PERSONAL CARE COMPOSITIONS | CONOPCO, INC., D/B/A UNILEVER (US) | 2011-05-12 | — | — | US | disclosed |
| US-20110110871-A1 | SUBSTITUTED 3-(PHENOXYMETHYL) BENZYL AMINES AND PERSONAL CARE COMPOSITIONS | CONOPCO, INC., D/B/A UNILEVER (US) | 2011-05-12 | — | — | US | disclosed |
| WO-2011054805-A1 | SUBSTITUTED 3-(PHENOXYMETHYL) BENZYL AMINES AND PERSONAL CARE COMPOSITIONS | UNILEVER PLC (GB) | 2011-05-12 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110110871-A1 | SUBSTITUTED 3-(PHENOXYMETHYL) BENZYL AMINES AND PERSONAL CARE COMPOSITIONS | TYR, CUTA, BRD3 | BCHE 1155/4885L3MBTL1 1694/4885MAPT 1160/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.